Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

Skin lesions in Carney Complex are caused by a gene change in some skin cells that leads to increased pigmentation and may lead to tumors.

Skin problems in patients with polycystic ovarian disease are linked to body weight, blood sugar, and hormone levels.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

Accurate diagnosis and treatment of hyperandrogenism in women require comprehensive evaluation of symptoms and hormone levels.

Benign conditions can mimic serious ones in postmenopausal hyperandrogenism, requiring careful diagnosis.

Continued research and awareness are needed to improve treatments for androgen-dependent diseases.

Ovarian stromal hyperplasia can cause high testosterone in postmenopausal women and is treated by removing the ovaries.

A special blood test helped find the overactive ovary in a teen with PCOS, and removing that ovary improved her condition.

Removing a hormone-producing adrenal tumor can stop hair loss in women with high testosterone levels.

Higher levels of the protein Pannexin-1 may play a role in hair loss in women with PCOS.

Mohamed Kandil suggests renaming Polycystic Ovary Syndrome to "Polyfollicular Anovulatory Androgenic Syndrome" to better describe its symptoms, but concerns exist that it may not cover all related issues like obesity and depression.

Hyperandrogenism is diagnosed using clinical signs, lab tests, and imaging.

More young women are getting diagnosed with PCOS, which can lead to other health problems, but early treatment can help.

Keratin mutations cause skin diseases and could lead to new treatments.

PCOS affects health and quality of life, with effective treatments available and a need for more research on alternative therapies.

Women with PCOS often experience depression and anxiety, affecting their quality of life.

The transgene likely activated an oncogene or interrupted a tumor suppressor gene, causing melanoma in mice.

Hirsutism can occur in women with PCOS even if their androgen levels are normal, making diagnosis challenging.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Hair loss in two ferrets was caused by ovarian tissue tumors, not adrenal issues.

Calculated testosterone values are reliable for assessing hyperandrogenemia in women, making direct measurement unnecessary.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

Polish medical societies recommend personalized treatment for PCOS based on the patient's specific symptoms and use the Rotterdam criteria for diagnosis.

Significant progress was made in understanding androgen excess disorders, but much is still unknown.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Probiotics and synbiotics might help manage hirsutism by improving insulin resistance.